Atopic Dermatitis: A Review of Diagnosis and Treatment

Overview

Journal J Pediatr Pharmacol Ther

Specialty Pediatrics

Date 2024 Dec 11

PMID 39659858

Authors

Jack Jeskey

Christine Kurien

Henry Blunk

Kiran Sehmi

Sathya Areti

Delena Nguyen

Robert Hostoffer

Affiliations

Soon will be listed here.

Abstract

Atopic dermatitis, more commonly known as atopic eczema, is a chronic, relapsing inflammatory skin disorder characterized by dry skin, localized erythematous rash, and intense pruritus. The clinical manifestations are variable and age dependent. As one of the most common skin disorders globally, atopic dermatitis poses a significant clinical and economic burden on affected patients. Individual treatment strategies are imperative in improving patient outcomes and reducing these burdens. Recent advances in understanding the genetic, immunologic, and environmental factors influencing atopic dermatitis have opened avenues for novel treatment modalities. This article highlights the clinical presentation, pathophysiology, diagnosis criteria, as well as current recommendations on treatment of atopic dermatitis.

References

Musters A, Mashayekhi S, Harvey J, Axon E, Lax S, Flohr C . Phototherapy for atopic eczema. Cochrane Database Syst Rev. 2021; 10:CD013870. PMC: 8552896. DOI: 10.1002/14651858.CD013870.pub2. View

Hengge U, Ruzicka T, Schwartz R, Cork M . Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol. 2005; 54(1):1-15. DOI: 10.1016/j.jaad.2005.01.010. View

Yepes-Nunez J, Guyatt G, Gomez-Escobar L, Perez-Herrera L, Chu A, Ceccaci R . Allergen immunotherapy for atopic dermatitis: Systematic review and meta-analysis of benefits and harms. J Allergy Clin Immunol. 2022; 151(1):147-158. DOI: 10.1016/j.jaci.2022.09.020. View

Boguniewicz M, Fonacier L, Guttman-Yassky E, Ong P, Silverberg J, Farrar J . Atopic dermatitis yardstick: Practical recommendations for an evolving therapeutic landscape. Ann Allergy Asthma Immunol. 2017; 120(1):10-22.e2. DOI: 10.1016/j.anai.2017.10.039. View

Contento M, Cline A, Russo M . Steroid Phobia: A Review of Prevalence, Risk Factors, and Interventions. Am J Clin Dermatol. 2021; 22(6):837-851. DOI: 10.1007/s40257-021-00623-6. View

Sidbury R, Alikhan A, Bercovitch L, Cohen D, Darr J, Drucker A . Guidelines of care for the management of atopic dermatitis in adults with topical therapies. J Am Acad Dermatol. 2023; 89(1):e1-e20. DOI: 10.1016/j.jaad.2022.12.029. View

Vakharia P, Silverberg J . Adult-Onset Atopic Dermatitis: Characteristics and Management. Am J Clin Dermatol. 2019; 20(6):771-779. DOI: 10.1007/s40257-019-00453-7. View

Tamagawa-Mineoka R, Katoh N . Atopic Dermatitis: Identification and Management of Complicating Factors. Int J Mol Sci. 2020; 21(8). PMC: 7215488. DOI: 10.3390/ijms21082671. View

Sroka-Tomaszewska J, Trzeciak M . Molecular Mechanisms of Atopic Dermatitis Pathogenesis. Int J Mol Sci. 2021; 22(8). PMC: 8074061. DOI: 10.3390/ijms22084130. View

10.

Boguniewicz M, Fonacier L, Guttman-Yassky E, Ong P, Silverberg J . Atopic Dermatitis Yardstick update. Ann Allergy Asthma Immunol. 2023; 130(6):811-820. DOI: 10.1016/j.anai.2023.03.010. View

11.

Abuabara K, Yu A, Okhovat J, Allen I, Langan S . The prevalence of atopic dermatitis beyond childhood: A systematic review and meta-analysis of longitudinal studies. Allergy. 2017; 73(3):696-704. PMC: 5830308. DOI: 10.1111/all.13320. View

12.

Samuel C, Cornman H, Kambala A, Kwatra S . A Review on the Safety of Using JAK Inhibitors in Dermatology: Clinical and Laboratory Monitoring. Dermatol Ther (Heidelb). 2023; 13(3):729-749. PMC: 9930707. DOI: 10.1007/s13555-023-00892-5. View

13.

Ridd M, Santer M, MacNeill S, Sanderson E, Wells S, Webb D . Effectiveness and safety of lotion, cream, gel, and ointment emollients for childhood eczema: a pragmatic, randomised, phase 4, superiority trial. Lancet Child Adolesc Health. 2022; 6(8):522-532. DOI: 10.1016/S2352-4642(22)00146-8. View

14.

McDowell L, Olin B . Crisaborole: A Novel Nonsteroidal Topical Treatment for Atopic Dermatitis. J Pharm Technol. 2021; 35(4):172-178. PMC: 6600556. DOI: 10.1177/8755122519844507. View

15.

Williams H . Established corticosteroid creams should be applied only once daily in patients with atopic eczema. BMJ. 2007; 334(7606):1272. PMC: 1892503. DOI: 10.1136/bmj.39195.636319.80. View

16.

Mikhaylov D, Ungar B, Renert-Yuval Y, Guttman-Yassky E . Oral Janus kinase inhibitors for atopic dermatitis. Ann Allergy Asthma Immunol. 2023; 130(5):577-592. DOI: 10.1016/j.anai.2023.01.020. View

17.

Harvey J, Lax S, Lowe A, Santer M, Lawton S, Langan S . The long-term safety of topical corticosteroids in atopic dermatitis: A systematic review. Skin Health Dis. 2023; 3(5):e268. PMC: 10549798. DOI: 10.1002/ski2.268. View

18.

Stacey S, McEleney M . Topical Corticosteroids: Choice and Application. Am Fam Physician. 2021; 103(6):337-343. View

19.

Smith E, Chan M . Inflammatory Dermatopathology for General Surgical Pathologists. Clin Lab Med. 2017; 37(3):673-696. DOI: 10.1016/j.cll.2017.05.008. View

20.

Silverberg J, Hanifin J . Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population-based study. J Allergy Clin Immunol. 2013; 132(5):1132-8. DOI: 10.1016/j.jaci.2013.08.031. View